Non-Parallel Dysarthric Speech Enhancement Using CycleGAN-VC2 and Melgan with Ablation Validation
Deploying dysarthric speech enhancement in clinical settings runs into a hard practical wall: collecting matched recordings from patients across multiple sessions is rarely achievable because medication timing, motor fatigue, and dayto-day articulatory variability work against the frame-aligned parallel corpora that co...